Revisiting resistant hypertension: a comprehensive review
Internal Medicine Journal · 2023-10 · 53 (10) · 1739-1751
DOI: 10.1111/imj.16189 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Internal Medicine Journal, online erschienen am 26.07.2023. Verfasst von Ryan J Chan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, University of Ottawa and the Ottawa Hospital, Ottawa, Ontario, Canada. Hauptthemen laut MEDLINE: Hypertension. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Department of Medicine, University of Ottawa, Department of Medicine, Georgetown University.
Abstract (Originalsprache)
Resistant hypertension (RHT) is typically defined as blood pressure that remains above guideline‐directed targets despite the use of three anti‐hypertensives, usually including a diuretic, at optimal or maximally tolerated doses. It is generally estimated to affect 10–30% of those diagnosed with hypertension, though the true incidence might be lower after one factor in the prevalence of non‐adherence. Risk factors for its development include diabetes, obesity and other adverse lifestyle factors, and a diagnosis of RHT confers a greater risk of adverse cardiovascular outcomes, such as stroke, heart failure and mortality. It is essential to exclude pseudoresistance and secondary hypertension and to ensure non‐pharmacologic management is optimised prior to consideration of fourth‐line anti‐hypertensive agents or advanced interventions, such as device therapies. In this review, we will cover the different definitions of RHT, along with the importance of careful diagnosis and management strategies, and discuss newer agents and research needs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Department of Medicine, University of Ottawa and the Ottawa Hospital, Ottawa, Ontario, Canada.
- Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
- Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
ORCID-Profile: Swapnil S Hiremath
Förderung
- Department of Medicine, University of Ottawa
- Department of Medicine, Georgetown University
Zitieren
APA
Chan, R. J., Helmeczi, W., & Hiremath, S. S. (2023). Revisiting resistant hypertension: a comprehensive review. Internal Medicine Journal, 53(10), 1739-1751. https://doi.org/10.1111/imj.16189
Vancouver
Chan RJ, Helmeczi W, Hiremath SS. Revisiting resistant hypertension: a comprehensive review. Internal Medicine Journal. 2023;53(10):1739-1751. doi:10.1111/imj.16189
BibTeX
@article{Chan2023,
author = {Chan, Ryan J and Helmeczi, Wryan and Hiremath, Swapnil S},
title = {Revisiting resistant hypertension: a comprehensive review},
journal = {Internal Medicine Journal},
year = {2023},
volume = {53},
number = {10},
pages = {1739--1751},
doi = {10.1111/imj.16189}
}
EUVIMED